Design and evaluation of a fiberoptic fluorescence guided laser recanalization system

Current angioplasty techniques for recanalization of totally occluded arteries are limited by the inability to cross the occlusion and by the risk of perforation. A fiberoptic fluorescence guided laser recanalization system was developed and evaluated in vitro for recanalization of 17 human femoral or tibial totally occluded arterial segments (length 1.9–6.8 cm, diameter 2.5–6.0 mm). A 400 or 600 μm silica fiber was coupled to a helium‐cadmium laser (λ = 325 nm) for fluorescence excitation and to a holmium: YAG laser (λ = 2.1 μm) for tissue ablation. Fluorescence was recorded during recanalization after every other holmium laser pulse. During recanalization, each arterial segment was bent 30–90 degrees with respect to the fiber to simulate arterial tortuosity. Ablation continued with fiber advancement as long as the fluorescence confirmed that the target tissue was atherosclerotic. Arterial spectra were classified as normal or atherosclerotic by an on‐line computerized fluorescence classification algorithm (sensitivity 93%, specificity 95%). Normal fluorescence necessitated redirection of the fiber > 30 times per segment to continue recanalization. Fifteen of 17 totally occluded arteries had multiple recanalization channels created following total energy delivery of 40–1,016 Joules per segment with no angiographic or histologic evidence of laser perforation. Two heavily calcified arterial occlusions were not recanalized due to inhibition of holmium: YAG laser ablation by the recording of normal fluorescence spectra. Therefore, this fluorescence guided laser recanalization system appears safe and effective for recanalization of totally occluded arteries and merits in vivo evaluation. However, the lower sensitivity of fluorescence detection of heavily calcified plaques may limit the efficacy (but not safety) of fluorescence guided recanalization of heavily calcified occlusions.

[1]  H. Schaff,et al.  Angioplasty in total coronary artery occlusion. , 1984, Journal of the American College of Cardiology.

[2]  R. S. Mitchell,et al.  Percutaneous transluminal laser angioplasty for treatment of peripheral vascular disease. Clinical experience with 16 patients. , 1985, Radiology.

[3]  R. Siegel,et al.  PERCUTANEOUS ULTRASONIC ANGIOPLASTY: INITIAL CLINICAL EXPERIENCE , 1989, The Lancet.

[4]  L. Deckelbaum,et al.  Discrimination of normal and atherosclerotic aorta by laser‐induced fluorescence , 1987, Lasers in surgery and medicine.

[5]  M H Lee,et al.  Limitations, risks and complications of laser recanalization: a cautious approach warranted. , 1985, The American journal of cardiology.

[6]  Massoud Motamedi,et al.  Fluorescence Spectra Of Normal And Atherosclerotic Human Aorta: Optimum Discriminant Analysis , 1989, Photonics West - Lasers and Applications in Science and Engineering.

[7]  W. Henry,et al.  Laser-assisted thermal angioplasty in human peripheral artery occlusions: mechanism of recanalization. , 1989, Journal of the American College of Cardiology.

[8]  R. Anderson,et al.  Selective ablation of atheromas using a flashlamp-excited dye laser at 465 nm. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[9]  B. Höfling,et al.  PERCUTANEOUS REMOVAL OF ATHEROMATOUS PLAQUES IN PERIPHERAL ARTERIES , 1988, The Lancet.

[10]  A. Gallino,et al.  Percutaneous transluminal angioplasty of the arteries of the lower limbs: a 5 year follow-up. , 1984, Circulation.

[11]  W Rutishauser,et al.  Percutaneous transluminal coronary angioplasty for chronic total coronary arterial occlusion. , 1987, The American journal of cardiology.

[12]  L. Deckelbaum,et al.  Fluorescence spectroscopy guidance of laser ablation of atherosclerotic plaque , 1989 .

[13]  R. R. Murray,et al.  Long-segment femoropopliteal stenoses: is angioplasty a boon or a bust? , 1987, Radiology.

[14]  A F Gmitro,et al.  Measurement depth of laser-induced tissue fluorescence with application to laser angioplasty. , 1988, Applied optics.

[15]  R. F. Donaldson,et al.  Reduction of laser-induced pathologic tissue injury using pulsed energy delivery. , 1985, The American journal of cardiology.

[16]  P. Teirstein,et al.  Fluorescence-guided laser-assisted balloon angioplasty in patients with femoropopliteal occlusions. , 1990, Circulation.

[17]  G. Vetrovec,et al.  Early and late outcome of percutaneous transluminal coronary angioplasty for subacute and chronic total coronary occlusion. , 1986, American heart journal.

[18]  S. Kelsey,et al.  Percutaneous transluminal coronary angioplasty: report from the Registry of the National Heart, Lung, and Blood Institute. , 1982, The American journal of cardiology.

[19]  L. Richardson Richardson's Combination of Verhoff's Elastic and Gomori's Trichrome Stains with Modifications , 1975 .

[20]  M. Feld,et al.  Diagnosis of fibrous arterial atherosclerosis using fluorescence. , 1985, Applied optics.

[21]  In vivo ultrasound arterial recanalization of atherosclerotic total occlusions. , 1990, Journal of the American College of Cardiology.

[22]  P. Cipriano,et al.  Transluminal atherectomy for occlusive peripheral vascular disease. , 1988, The American journal of cardiology.

[23]  W. Roberts,et al.  Morphometric analysis of the composition of atherosclerotic plaques in the four major epicardial coronary arteries in acute myocardial infarction and in sudden coronary death. , 1989, Circulation.

[24]  D. Kereiakes,et al.  Angioplasty in total coronary artery occlusion: experience in 76 consecutive patients. , 1985, Journal of the American College of Cardiology.

[25]  C. Zarins,et al.  Long-segment arterial occlusion: percutaneous transluminal angioplasty. , 1982, AJR. American journal of roentgenology.

[26]  C. McCabe,et al.  Initial success and long-term follow-up of percutaneous transluminal coronary angioplasty in chronic total occlusions versus conventional stenoses. , 1988, The American journal of cardiology.

[27]  M A Konstam,et al.  The excimer laser: gross, light microscopic and ultrastructural analysis of potential advantages for use in laser therapy of cardiovascular disease. , 1985, Journal of the American College of Cardiology.

[28]  J. Isner,et al.  Spectroscopic characterization of cardiovascular tissue , 1988, Lasers in surgery and medicine.

[29]  P J Breslau,et al.  Percutaneous transluminal angioplasty of the femoropopliteal artery: initial and long-term results. , 1985, Radiology.

[30]  C. Conti,et al.  Laser angioplasty with angioscopic guidance in humans. , 1986, Journal of the American College of Cardiology.

[31]  M. Keane,et al.  Effect of systemic pH on models of altered ileal transport in the rat. , 1989, Gastroenterology.

[32]  R S Balaban,et al.  Human arterial surface fluorescence: atherosclerotic plaque identification and effects of laser atheroma ablation. , 1988, Journal of the American College of Cardiology.

[33]  W S Grundfest,et al.  Laser ablation of human atherosclerotic plaque without adjacent tissue injury. , 1985, Journal of the American College of Cardiology.

[34]  M. P. Judkins,et al.  Transluminal Treatment of Arteriosclerotic Obstruction: Description of a New Technic and a Preliminary Report of Its Application , 1964, Circulation.

[35]  L. Deckelbaum,et al.  Change in laser‐induced arterial fluorescence during ablation of atherosclerotic plaque , 1989, Lasers in Surgery and Medicine.

[36]  H. Hirzel,et al.  Percutaneous transluminal coronary angioplasty: late results at 5 years following intervention. , 1985, American heart journal.

[37]  K.M. O'Brien,et al.  Development and evaluation of spectral classification algorithms for fluorescence guided laser angioplasty , 1989, IEEE Transactions on Biomedical Engineering.

[38]  V. Utermohlen,et al.  LYMPHOCYTE AGGLUTINATION IN MULTIPLE SCLEROSIS , 1975, The Lancet.